GrowingStockReport.com

BioLineRx, Ltd. (NASDAQ:BLRX) and the Wendy's Company (NASDAQ:WEN) Added to Growing Stock Report's NASDAQ Active Stock Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 02/12/2014 -- Growing Stock Report expands its NASDAQ Active Stock Watch List adding BioLineRx, Ltd. (NASDAQ:BLRX) and The Wendy's Company (NASDAQ:WEN).

BioLineRx, Ltd. (NASDAQ:BLRX) a clinical stage biopharmaceutical development company that engages in identifying, in-licensing, and developing therapeutic candidates is currently down (-3.08%) on 463,901 shares traded after BioLineRx Announced Positive Preclinical Results for Novel Treatment for Chronic Myeloid Leukemia. BioLineRx, Ltd. (NASDAQ:BLRX) is currently down (-30.15%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about BioLineRx, Ltd. (NASDAQ:BLRX)

The Wendy's Company (NASDAQ:WEN) the parent company of its 100% owned subsidiary holding company Wendy’s Restaurants, LLC is currently up (+1.09%) on 6,439,476 shares traded after The Wendy's Company Announced Preliminary Results Of Tender Offer. The Wendy's Company (NASDAQ:WEN) is currently up (+79.73%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about The Wendy's Company (NASDAQ:WEN)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com